Toward the end of trading Monday, the Dow traded down 0.74% to 34,225.89 while the NASDAQ rose 0.45% to 14,132.55. The S&P also fell, dropping 0.27% to 4,236.03.
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 33,462,280 cases with around 599,760 deaths. India confirmed a total of at least 29,510,410 cases and 374,300 deaths, while Brazil reported over 17,412,760 COVID-19 cases with 487,400 deaths. In total, there were at least 176,001,660 cases of COVID-19 worldwide with more than 3,805,010 deaths, according to data compiled by Johns Hopkins University.
Leading and Lagging Sectors
Information technology shares climbed 0.6% on Monday. Meanwhile, top gainers in the sector included Canaan Inc. CAN 17.55%, up 21%, and Corsair Gaming, Inc. CRSR 12.79%, up 26%.
In trading on Monday, materials shares fell 1.7%.
Top Headline
Accenture PLC ACN 0.09% agreed to acquire Aachen, Germany's engineering consulting and services firm, umlaut.
The financial terms of the transaction remain undisclosed
Equities Trading UP
Enochian Biosciences, Inc. ENOB 60.66% shares shot up 100% to $8.81. The FDA has accepted Enochian BioSciences Inc's pre-IND (Investigational New Drug) request for a potential functional cure or treatment of HIV.
Shares of RAPT Therapeutics, Inc. RAPT 119.2% got a boost, shooting 116% to $40.16 as the company announced topline results from its Phase 1b trial of RPT193 as monotherapy for moderate-to-severe atopic dermatitis (AD).
iTeos Therapeutics, Inc. ITOS 37.24% shares were also up, gaining 37% to $27.47. iTeos Therapeutics and GlaxoSmithKline plc have agreed to co-develop and co-commercialize EOS-448, an anti-TIGIT monoclonal antibody.
Equities Trading DOWN
Washington Prime Group Inc. WPG 31.2% shares tumbled 30% to $3.40 after the company filed for Chapter 11 bankruptcy.
Shares of Avenue Therapeutics, Inc. ATXI 30.63% were down 29% to $2.97 after the company received a second Complete Response Letter from the FDA regarding its marketing application seeking approval for IV tramadol.
Inhibikase Therapeutics, Inc. IKT 18.4% was down, falling 19% to $4.8750. Inhibikase Therapeutics filed for offering of up to 8 million shares of common stock.
Commodities
In commodity news, oil traded down 0.2% to $70.74, while gold traded down 0.8% to $1,865.30.
Silver traded down 0.5% Monday to $28.01 while copper fell 0.3% to $4.5245.
Euro zone
European shares closed mostly higher today. The eurozone’s STOXX 600 gained 0.18%, the Spanish Ibex Index rose 0.83% and the German DAX 30 fell 0.13%. Meanwhile, the London’s FTSE 100 gained 0.18%, French CAC 40 climbed 0.24% and Italy’s FTSE MIB rose 0.16%.
Eurozone industrial production increased 0.8% in April versus a revised 0.4% rise in the previous month.
Economics
There are no major economic releases for Monday.
Benzinga does not provide investment advice. All rights reserved.
Recommended Content
Editors’ Picks
EUR/USD edges lower toward 1.0700 post-US PCE
EUR/USD stays under modest bearish pressure but manages to hold above 1.0700 in the American session on Friday. The US Dollar (USD) gathers strength against its rivals after the stronger-than-forecast PCE inflation data, not allowing the pair to gain traction.
GBP/USD retreats to 1.2500 on renewed USD strength
GBP/USD lost its traction and turned negative on the day near 1.2500. Following the stronger-than-expected PCE inflation readings from the US, the USD stays resilient and makes it difficult for the pair to gather recovery momentum.
Gold struggles to hold above $2,350 following US inflation
Gold turned south and declined toward $2,340, erasing a large portion of its daily gains, as the USD benefited from PCE inflation data. The benchmark 10-year US yield, however, stays in negative territory and helps XAU/USD limit its losses.
Bitcoin Weekly Forecast: BTC’s next breakout could propel it to $80,000 Premium
Bitcoin’s recent price consolidation could be nearing its end as technical indicators and on-chain metrics suggest a potential upward breakout. However, this move would not be straightforward and could punish impatient investors.
Week ahead – Hawkish risk as Fed and NFP on tap, Eurozone data eyed too
Fed meets on Wednesday as US inflation stays elevated. Will Friday’s jobs report bring relief or more angst for the markets? Eurozone flash GDP and CPI numbers in focus for the Euro.